SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-094469
Filing Date
2022-08-25
Accepted
2022-08-25 17:01:43
Documents
15
Period of Report
2022-06-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2224433d1_8ka.htm   iXBRL 8-K/A 29358
2 EXHIBIT 23.1 tm2224433d1_ex23-1.htm EX-23.1 2158
3 EXHIBIT 99.1 tm2224433d1_ex99-1.htm EX-99.1 635204
4 EXHIBIT 99.2 tm2224433d1_ex99-2.htm EX-99.2 141369
  Complete submission text file 0001104659-22-094469.txt   1057350

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA egrx-20220609.xsd EX-101.SCH 3030
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20220609_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20220609_pre.xml EX-101.PRE 22593
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2224433d1_8ka_htm.xml XML 4962
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 221198450
SIC: 2834 Pharmaceutical Preparations